查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1876805

家庭输液治疗市场机会、成长驱动因素、产业趋势分析及预测（2025-2034年）

Home Infusion Therapy Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球家庭输液治疗市场价值为 366 亿美元，预计到 2034 年将以 9.2% 的复合年增长率增长至 898 亿美元。

家庭输液治疗市场 - IMG1

市场扩张的驱动因素包括慢性病盛行率的上升、对经济高效医疗解决方案的需求、输液技术的进步以及老年人口的成长。家庭输液疗法是指在患者家中，透过静脉注射 (IV) 或皮下注射的方式，将药物或营养物质直接输送到患者的血液中。这种疗法通常用于长期使用抗生素、化疗药物、疼痛管理和肠外营养。癌症、糖尿病、胃肠道疾病、免疫缺陷和心臟衰竭等慢性病发病率的不断上升是推动市场需求成长的主要因素。居家输液疗法使患者能够在医院外接受持续、安全的治疗，从而减轻医疗系统的压力，同时提高患者的便利性和舒适度。便携式输液帮浦、智慧型设备和远端监控系统的引入，进一步确保了安全性、精确的剂量控制以及患者与医护人员之间的即时沟通，从而推动了家庭输液疗法的广泛应用。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 366亿美元
预测值 898亿美元
复合年增长率 9.2%

由于输液帮浦在慢性病管理和居家照护中发挥着至关重要的作用，预计到2024年，输液帮浦市场占有率将达到52.7%。这些设备能够对疼痛管理、荷尔蒙治疗和心臟药物等疗法进行可编程且精确的给药，从而降低输液不足或过量的风险。其精准性和可靠性使其成为确保居家治疗安全的关键。

2024年，直销通路的市占率达到71.1%，预计到2034年将达到627亿美元。这种模式使製造商能够透过消除中间商利润来提供更具竞争力的价格。大量采购优惠和长期协议吸引了寻求成本效益的医疗机构，从而促进了输液泵、静脉输液套装及相关耗材的普及。

2024年，北美家庭输液治疗市占率达44.2%。该地区慢性疾病（如癌症、糖尿病、克隆氏症和免疫缺陷）的高发生率推动了对长期静脉输液治疗的强劲需求。美国和加拿大不断成长的患者群体也支撑着家庭输液治疗服务的稳定发展。

全球家庭输液治疗市场的主要参与者包括ICU Medical、Terumo、Fresenius Kabi、Moog、Mindray、B. Braun、Baxter、Nipro、JMS、Avanos（Halyard Health）、Contec Medical Systems、Polymed、Erenler Medikal、AMSINO和Becton Dickinson and Company。这些公司采用多种策略来巩固其市场地位。他们专注于持续创新，开发便携式、用户友好的输液泵，并配备先进的安全技术和远端监控功能。与医院、诊所和家庭医疗保健服务提供者建立策略合作伙伴关係，可以拓展分销网络并提升信誉度。向新兴市场进行地理扩张，有助于接触新的患者群体，而併购则有助于整合技术和产品组合。

目录

第一章：方法论与范围

第二章：执行概要

第三章：行业洞察

  • 产业生态系分析
  • 产业影响因素
    • 成长驱动因素
      • 医院感染病例不断增加
      • 慢性病盛行率上升
      • 技术进步
      • 老年人口不断增加
      • 人们对居家医疗保健解决方案的偏好日益增强
    • 产业陷阱与挑战
      • 缺乏报销
      • 家用输液设备的安全隐忧与故障风险
    • 市场机会
      • 静脉注射免疫球蛋白（IVIG）疗法的应用日益增多
      • 对个人化照护的需求日益增长
  • 成长潜力分析
  • 监管环境
    • 北美洲
    • 欧洲
    • 亚太地区
  • 技术格局
    • 当前技术趋势
    • 新兴技术
  • 报销方案
  • 家庭输液治疗产业的趋势
  • 2024年定价分析
  • 家庭输液治疗产业的未来前景
  • 波特的分析
  • PESTEL 分析
  • 差距分析
  • 创业场景
  • 消费者行为分析
  • 价值链分析

第四章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
    • 全球的
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
  • 竞争定位矩阵
  • 主要市场参与者的竞争分析
  • 关键进展
    • 併购
    • 合作伙伴关係与合作
    • 新产品发布
    • 扩张计划

第五章：市场估算与预测：依产品划分，2021-2034年

  • 主要趋势
  • 点滴帮浦
    • 注射器
    • 体积
    • 门诊
    • 胰岛素
    • 其他输液泵
  • 无针头连接器
  • 静脉输液装置
  • 静脉导管

第六章：市场估算与预测：依应用领域划分，2021-2034年

  • 主要趋势
  • 抗感染
  • 肠内营养
  • 特种药品
  • 肠外营养
  • 水合
  • 化疗
  • 其他应用

第七章：市场估计与预测：依配销通路划分，2021-2034年

  • 主要趋势
  • 直销
  • 间接销售

第八章：市场估算与预测：依地区划分，2021-2034年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第九章：公司简介

  • AMSINO
  • B. BRAUN
  • Baxter
  • Becton Dickinson and Company
  • Contec Medical Systems
  • ERENLER MEDIKAL
  • FRESENIUS KABI
  • Halyard Health (AVANOS)
  • ICU Medical
  • JMS
  • Mindray
  • Moog
  • NIPRO
  • POLYMED
  • TERUMO
简介目录
Product Code: 435

The Global Home Infusion Therapy Market was valued at USD 36.6 billion in 2024 and is estimated to grow at a CAGR of 9.2% to reach USD 89.8 billion by 2034.

Home Infusion Therapy Market - IMG1

Market expansion is driven by the rising prevalence of chronic diseases, the shift toward cost-effective healthcare solutions, advancements in infusion technologies, and the growing elderly population. Home infusion therapy involves delivering drugs or nutrients directly into a patient's bloodstream via intravenous (IV) or subcutaneous methods in a home setting. This therapy is commonly applied for antibiotics, chemotherapy, pain management, and parenteral nutrition over prolonged periods. The increasing incidence of chronic conditions such as cancer, diabetes, gastrointestinal disorders, immune deficiencies, and heart failure is a major factor boosting demand. Home infusion therapy allows patients to receive continuous and safe treatment outside hospital facilities, reducing pressure on healthcare systems while enhancing convenience and comfort. The introduction of portable infusion pumps, smart devices, and remote monitoring systems further ensures safety, precise dosing, and real-time communication between patients and healthcare providers, driving broader adoption.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$36.6 Billion
Forecast Value$89.8 Billion
CAGR9.2%

The infusion pumps segment accounted for 52.7% share in 2024 owing to their essential role in chronic disease management and home care. These devices provide programmable and accurate dosing for therapies such as pain management, hormone treatments, and cardiac medications, reducing the risk of under- or over-infusion. Their precision and reliability make them critical for ensuring safe therapy in home settings.

The direct sales captured a share of 71.1% in 2024 and are expected to reach USD 62.7 billion through 2034. This approach allows manufacturers to offer competitive pricing by eliminating intermediary margins. Bulk purchase incentives and long-term agreements attract healthcare providers seeking cost efficiency, boosting the adoption of infusion pumps, IV kits, and associated disposables.

North America Home Infusion Therapy Market held a 44.2% share in 2024. The region's high prevalence of chronic illnesses such as cancer, diabetes, Crohn's disease, and immune deficiencies has driven strong demand for long-term IV therapies. The growing patient population in the U.S. and Canada is supporting steady growth in home infusion therapy services.

Prominent players in the Global Home Infusion Therapy Market include ICU Medical, Terumo, Fresenius Kabi, Moog, Mindray, B. Braun, Baxter, Nipro, JMS, Avanos (Halyard Health), Contec Medical Systems, Polymed, Erenler Medikal, AMSINO, and Becton Dickinson and Company. Companies in the Home Infusion Therapy Market employ several strategies to strengthen their presence and market position. They focus on continuous innovation, developing portable and user-friendly infusion pumps with advanced safety and remote monitoring features. Strategic partnerships with hospitals, clinics, and home healthcare providers expand distribution networks and enhance credibility. Geographic expansion into emerging markets allows access to new patient populations, while mergers and acquisitions help consolidate technology and product portfolios.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product trends
    • 2.2.3 Application trends
    • 2.2.4 Distribution channel trends
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing hospital acquired infections
      • 3.2.1.2 Rising prevalence of chronic diseases
      • 3.2.1.3 Advancements in technology
      • 3.2.1.4 Growing geriatric population
      • 3.2.1.5 Increasing preference towards at-home healthcare solutions
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Dearth of reimbursement
      • 3.2.2.2 Safety concerns and risk of failure associated with home infusion devices
    • 3.2.3 Market opportunities
      • 3.2.3.1 Increasing adoption of intravenous immunoglobulin (IVIG) therapy
      • 3.2.3.2 Growing demand for personalized care
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Reimbursement scenario
  • 3.7 Trends in home infusion therapy industry
  • 3.8 Pricing analysis, 2024
  • 3.9 Future prospects for home infusion therapy industry
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis
  • 3.12 Gap analysis
  • 3.13 Start-up scenario
  • 3.14 Consumer behaviour analysis
  • 3.15 Value chain analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
    • 4.3.5 LAMEA
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Infusion pumps
    • 5.2.1 Syringe
    • 5.2.2 Volumetric
    • 5.2.3 Ambulatory
    • 5.2.4 Insulin
    • 5.2.5 Other infusion pumps
  • 5.3 Needleless connectors
  • 5.4 Intravenous sets
  • 5.5 IV cannulas

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Anti-infective
  • 6.3 Enteral nutrition
  • 6.4 Specialty pharmaceuticals
  • 6.5 Parenteral nutrition
  • 6.6 Hydration therapy
  • 6.7 Chemotherapy
  • 6.8 Other applications

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Direct sales
  • 7.3 Indirect sales

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 AMSINO
  • 9.2 B. BRAUN
  • 9.3 Baxter
  • 9.4 Becton Dickinson and Company
  • 9.5 Contec Medical Systems
  • 9.6 ERENLER MEDIKAL
  • 9.7 FRESENIUS KABI
  • 9.8 Halyard Health (AVANOS)
  • 9.9 ICU Medical
  • 9.10 JMS
  • 9.11 Mindray
  • 9.12 Moog
  • 9.13 NIPRO
  • 9.14 POLYMED
  • 9.15 TERUMO